Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Functional Genomics and Translational Biology; American College of Cardiology

doi:10.1161/CIR.0000000000000239

Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, American College of Cardiology

Medicine, Cardiology Division

Research output: Contribution to journal › Review article › peer-review

266 Scopus citations

Original language	English (US)
Pages (from-to)	e273-e280
Journal	Circulation
Volume	132
Issue number	22
DOIs	https://doi.org/10.1161/CIR.0000000000000239
State	Published - Dec 1 2015

Keywords

AHA Scientific Statements
arrhythmogenic right ventricular cardiomyopathy
athletes
cardiomyopathy
cardiovascular abnormalities
cardiovascular magnetic resonance
hypertrophic cardiomyopathy
myocarditis
sudden death

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIR.0000000000000239

Cite this

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, & American College of Cardiology (2015). Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology. Circulation, 132(22), e273-e280. https://doi.org/10.1161/CIR.0000000000000239

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology ; Council on Cardiovascular Disease in the Young ; Council on Cardiovascular and Stroke Nursing et al. / Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities : Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology. In: Circulation. 2015 ; Vol. 132, No. 22. pp. e273-e280.

@article{a8c19c6d643e4bfd99629e7c5ccfa15e,

title = "Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology",

keywords = "AHA Scientific Statements, arrhythmogenic right ventricular cardiomyopathy, athletes, cardiomyopathy, cardiovascular abnormalities, cardiovascular magnetic resonance, hypertrophic cardiomyopathy, myocarditis, sudden death",

author = "{on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology} and {Council on Cardiovascular Disease in the Young} and {Council on Cardiovascular and Stroke Nursing} and {Council on Functional Genomics and Translational Biology} and {American College of Cardiology} and Maron, {Barry J.} and Udelson, {James E.} and Bonow, {Robert O.} and Nishimura, {Rick A.} and Ackerman, {Michael J.} and Estes, {N. A.Mark} and Cooper, {Leslie T.} and Link, {Mark S.} and Maron, {Martin S.}",

year = "2015",

month = dec,

day = "1",

doi = "10.1161/CIR.0000000000000239",

language = "English (US)",

volume = "132",

pages = "e273--e280",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "22",

}

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology & American College of Cardiology 2015, 'Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology', Circulation, vol. 132, no. 22, pp. e273-e280. https://doi.org/10.1161/CIR.0000000000000239

Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology. / on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing et al.
In: Circulation, Vol. 132, No. 22, 01.12.2015, p. e273-e280.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities

T2 - Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology

AU - on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology

AU - Council on Cardiovascular Disease in the Young

AU - Council on Cardiovascular and Stroke Nursing

AU - Council on Functional Genomics and Translational Biology

AU - American College of Cardiology

AU - Maron, Barry J.

AU - Udelson, James E.

AU - Bonow, Robert O.

AU - Nishimura, Rick A.

AU - Ackerman, Michael J.

AU - Estes, N. A.Mark

AU - Cooper, Leslie T.

AU - Link, Mark S.

AU - Maron, Martin S.

PY - 2015/12/1

Y1 - 2015/12/1

KW - AHA Scientific Statements

KW - arrhythmogenic right ventricular cardiomyopathy

KW - athletes

KW - cardiomyopathy

KW - cardiovascular abnormalities

KW - cardiovascular magnetic resonance

KW - hypertrophic cardiomyopathy

KW - myocarditis

KW - sudden death

UR - http://www.scopus.com/inward/record.url?scp=84949324348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949324348&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000239

DO - 10.1161/CIR.0000000000000239

M3 - Review article

C2 - 26621644

AN - SCOPUS:84949324348

SN - 0009-7322

VL - 132

SP - e273-e280

JO - Circulation

JF - Circulation

IS - 22

ER -

on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, American College of Cardiology. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 1;132(22):e273-e280. doi: 10.1161/CIR.0000000000000239

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this